Pfizer buying Hospira for about $15.23 billion
Thursday, February 5, 2015 - 09:00
in Mathematics & Economics
(AP)—Pfizer is buying Hospira for approximately $15.23 billion, saying it is a good fit with its global established pharmaceutical business.